论文部分内容阅读
江苏制药企业同科研、教学单位密切配合,研制了一批医药新产品:主要有抗寄生虫药物吡喹酮,抗肿瘤药物抗癌平,心血管类用药达舒平、心电安、常药降压片、尿激酶、去脂舒,止喘药物敏喘宁、喘敌素、药用中性蛋白酶,抗抑郁药阿米替林,血液用药咖啡酸咖啡酸胺,抗组织胺药物赛庚啶,眼病用药治障宁,现将其中未曾公开介绍的药物简要报导如下:吡喹酮:广谱抗寄生虫药物,对日本、曼氏、埃及血吸虫病疗效显著,对绦虫、肺吸虫、肝吸虫病亦有良好的作用。由南京药物研究所、南京制药厂研制。南京制药厂试产。尿激酶适用于急性脑血栓和脑血管栓塞、周围血管血栓形成、视网膜中央静脉血拴形成、肾移植及
Jiangsu pharmaceutical companies work closely with scientific research and teaching units to develop a number of new pharmaceutical products: praziquantel, anti-parasitic drugs, anticancer drugs, cardiovascular drugs, Antihypertensive tablets, urokinase, lipid-lowering Shu, antiasthmatic drugs Minchuan, Cholesterol, neutral protease drugs, antidepressants amitriptyline, blood drug caffeic acid amine, antihistamine Cypriot Drugs used in the treatment of ocular diseases are as follows: Praziquantel: A broad-spectrum antiparasitic drug that has significant efficacy against schistosomiasis japonica, mansonna, and Egypt, and is effective against tapeworms, paragonimiasis, liver Trematosis also has a good effect. Developed by Nanjing Institute of Materia Medica and Nanjing Pharmaceutical Factory. Nanjing Pharmaceutical Factory trial production. Urokinase for acute cerebral thrombosis and cerebrovascular embolism, peripheral vascular thrombosis, retinal central vein tethering, kidney transplantation and